On December 17, 2020, clinicians from Maastro Proton Therapy in the Netherlands shared their insights and first experiences treating breast cancer with the MEVION S250i Proton Therapy System and natively integrated image-guidance solutions in a model-based environment.
Maastro walks through the entire process, including the planning, implementation phase, expectations, and overall results and first impressions.
The webinar recording is now available on-demand.
Maastro in the Netherlands is an internationally renowned radiotherapy center that focuses on the connection between patient care, education, and groundbreaking scientific research in conjunction with Maastricht University and Maastricht University Hospital.
Cutting-edge technology goes hand-in-hand with quality patient care. Maastro's mission is to guide patients through the healing process by offering sufficient information and high quality treatment. It is important to help patients gain a sense of control and composure during a difficult time like cancer treatment.
Maastro's state-of-the-art clinic includes the latest imaging and radiotherapy equipment and established its embedded proton therapy center in 2019. Maastro Proton Therapy was the first center in Europe to provide proton therapy with a compact, single-room system and began patient treatment within one year of accelerator delivery. The center treats various cancers, including lung, breast, brain, head and neck, lymphoma, bone, and esophagus, among which breast cancer accounts for 30% of all proton therapy cases.
In this webinar, the featured speakers Dr. Karolien Verhoeven and Dr. Mirko Unipan, discussed the following topics:
- Maastro Proton Therapy Overview
- Model-Based Selection & Experience
- Patient Workflow
- Treatment Planning
- Image Guidance & Treatment Delivery
- First Clinical Experience on Toxicity